Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.

de Vries-Sluijs TE, Hansen BE, van Doornum GJ, Kauffmann RH, Leyten EM, Mudrikova T, Brinkman K, den Hollander JG, Kroon FP, Janssen HL, van der Ende ME, de Man RA.

J Infect Dis. 2011 Apr 1;203(7):984-91. doi: 10.1093/infdis/jiq137. Epub 2011 Jan 25.

PMID:
21266513
2.

HIV transmission patterns among The Netherlands, Suriname, and The Netherlands Antilles: a molecular epidemiological study.

Kramer MA, Cornelissen M, Paraskevis D, Prins M, Coutinho RA, van Sighem AI, Sabajo L, Duits AJ, Winkel CN, Prins JM, van der Ende ME, Kauffmann RH, Op de Coul EL.

AIDS Res Hum Retroviruses. 2011 Feb;27(2):123-30. doi: 10.1089/aid.2010.0115. Epub 2010 Oct 7.

PMID:
20929384
3.

Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN).

Pogány K, van Valkengoed IG, Prins JM, Nieuwkerk PT, van der Ende I, Kauffmann RH, Kroon FP, Verbon A, Nievaard MF, Lange JM, Brinkman K.

J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):395-400. Erratum in: J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):607. Vanvalkengoed, Irene G [corrected to van Valkengoed, Irene G M].

PMID:
17195761
4.
5.

Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications.

la Porte CJ, Schippers EF, van der Ende ME, Koopmans PP, Blok WL, Kauffmann RH, Kroon FP, Burger DM.

AIDS. 2005 Jul 1;19(10):1105-7.

PMID:
15958844
6.

Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.

de Boer MG, Kroon FP, Kauffmann RH, Vriesendorp R, Zwinderman K, van Dissel JT.

Neth J Med. 2003 Dec;61(12):408-12.

7.

[Clinical reasoning and decision-making in practice. A young woman with fever, shortness of breath, and reduced consciousness].

Taal W, Kauffmann RH, Hart W, Vecht ChJ.

Ned Tijdschr Geneeskd. 2003 Jul 19;147(29):1404-8. Dutch.

PMID:
12894464
8.

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

Nieuwkerk PT, Sprangers MA, Burger DM, Hoetelmans RM, Hugen PW, Danner SA, van Der Ende ME, Schneider MM, Schrey G, Meenhorst PL, Sprenger HG, Kauffmann RH, Jambroes M, Chesney MA, de Wolf F, Lange JM; ATHENA Project.

Arch Intern Med. 2001 Sep 10;161(16):1962-8.

PMID:
11525698
9.

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.

Tan AC, Brouwer JT, Glue P, van Leusen R, Kauffmann RH, Schalm SW, de Vries RA, Vroom B.

Nephrol Dial Transplant. 2001 Jan;16(1):193-5. No abstract available.

PMID:
11209032
10.

Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.

Notermans DW, Pakker NG, Hamann D, Foudraine NA, Kauffmann RH, Meenhorst PL, Goudsmit J, Roos MT, Schellekens PT, Miedema F, Danner SA.

J Infect Dis. 1999 Oct;180(4):1050-6.

PMID:
10479130
11.

Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.

Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FW, Hamann D, van der Ende ME, Claessen FA, Kauffmann RH, Koopmans PP, Kroon FP, ten Napel CH, Sprenger HG, Weigel HM, Montaner JS, Lange JM, Reiss P, Schellekens PT, Miedema F.

AIDS. 1999 Feb 4;13(2):203-12.

PMID:
10202826
12.

Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods.

Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk H, van Loon AM, van Dijk WC, Kauffmann RH, Quint W, van Doorn LJ.

J Clin Microbiol. 1998 Jun;36(6):1711-5.

13.

[Chronic hepatitis C in hemodialysis patients].

Tan AC, Kauffmann RH, van Leusen R, Mulder CJ, Schalm SW, de Vries RA, Vroom BC.

Ned Tijdschr Geneeskd. 1997 Nov 22;141(47):2280-5. Review. Dutch.

PMID:
9550811
14.

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.

Notermans DW, Jurriaans S, de Wolf F, Foudraine NA, de Jong JJ, Cavert W, Schuwirth CM, Kauffmann RH, Meenhorst PL, McDade H, Goodwin C, Leonard JM, Goudsmit J, Danner SA.

AIDS. 1998 Jan 22;12(2):167-73.

PMID:
9468365
15.

A randomized trial of geriatric liaison intervention in elderly medical inpatients.

Slaets JP, Kauffmann RH, Duivenvoorden HJ, Pelemans W, Schudel WJ.

Psychosom Med. 1997 Nov-Dec;59(6):585-91.

PMID:
9407576
16.

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, Borleffs JC, Allworth T, Kauffmann RH, Jones P, Kroon FP, Verbrugh HA, de Marie S.

AIDS. 1997 Oct;11(12):1463-71.

PMID:
9342068
17.

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.

de Jong MD, Vella S, Carr A, Boucher CA, Imrie A, French M, Hoy J, Sorice S, Pauluzzi S, Chiodo F, Weverling GJ, van der Ende ME, Frissen PJ, Weigel HM, Kauffmann RH, Lange JM, Yoon R, Moroni M, Hoenderdos E, Leitz G, Cooper DA, Hall D, Reiss P.

J Infect Dis. 1997 Apr;175(4):966-70.

PMID:
9086161
18.

Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men.

Mulder CL, Antoni MH, Duivenvoorden HJ, Kauffmann RH, Goodkin K.

J Psychosom Res. 1995 Nov;39(8):957-65.

PMID:
8926605
19.

Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.

de Jong MD, Loewenthal M, Boucher CA, van der Ende I, Hall D, Schipper P, Imrie A, Weigel HM, Kauffmann RH, Koster R, et al.

J Infect Dis. 1994 Jun;169(6):1346-50.

PMID:
8195615
20.

Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.

Frissen PH, van der Ende ME, ten Napel CH, Weigel HM, Schreij GS, Kauffmann RH, Koopmans PP, Hoepelman AI, de Boer JB, Weverling GJ, et al.

J Infect Dis. 1994 Jun;169(6):1351-5.

PMID:
7910838
21.

Human immunodeficiency virus, fever, dyspnoea and a dry cough. Expect the unexpected?

in't Veen JC, Kauffmann RH.

Neth J Med. 1993 Aug;43(1-2):18-21.

PMID:
8232690
22.

AIDS without detectable HIV: a case report.

Tijhuis GJ, Huisman HG, Roos MT, Kauffmann RH.

Am J Med. 1993 Apr;94(4):442-3. Review. No abstract available.

PMID:
8097365
23.

Dialysis associated mucormycosis and desferrioxamine treatment: a case report with review of the role of oxygen radicals.

Seeverens HJ, Tijhuis GJ, Ruijs GJ, Kazzaz BA, Kauffmann RH.

Neth J Med. 1992 Dec;41(5-6):275-9. Review.

PMID:
1494406
24.

Infection with Dengue virus.

Melissant CF, Kauffmann RH.

Neth J Med. 1992 Dec;41(5-6):272-4.

PMID:
1494405
25.

Tubulointerstitial nephritis associated with pyrazinamide.

Sanwikarja S, Kauffmann RH, te Velde J, Serlie J.

Neth J Med. 1989 Feb;34(1-2):40-6.

PMID:
2915734
26.

Portosystemic encephalopathy in hereditary hemorrhagic telangiectasia.

Fagel WJ, Perlberger R, Kauffmann RH.

Am J Med. 1988 Dec;85(6):858-60. No abstract available.

PMID:
3195608
27.

[Glaphenine-induced intravascular hemolysis with acute kidney insufficiency as a consequence of IgG anti-glaphenine antibodies].

Roodnat JI, Kauffmann RH, Gerrits WB, van Zijl AM.

Ned Tijdschr Geneeskd. 1987 Dec 12;131(50):2316-20. Dutch. No abstract available.

PMID:
2892141
28.

Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy.

Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, van Es LA.

Kidney Int. 1984 Nov;26(5):760-6.

29.

Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy.

Valentijn RM, Radl J, Haayman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, van Es LA.

Contrib Nephrol. 1984;40:87-92. No abstract available.

PMID:
6499467
30.

The pathogenetic significance of circulating immune complexes.

Van Es LA, Daha MR, Valentijn RM, Kauffmann RH.

Neth J Med. 1984;27(9):350-8. Review. No abstract available.

PMID:
6083461
31.

The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.

Kauffmann RH, de Rooy-Dijk HH, Klein F, Lafeber GJ, Cats A, van Es LA.

Clin Exp Immunol. 1983 Oct;54(1):203-12.

32.

Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy.

Valentijn RM, Kauffmann RH, de la Rivière GB, Daha MR, Van ES LA.

Am J Med. 1983 Mar;74(3):375-81.

PMID:
6219575
33.

Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.

Daha MR, Bertina RM, Thompson J, Kauffmann RH, Nicholson-Weller A, Veltkamp JJ, Briët E.

Clin Exp Immunol. 1982 Jun;48(3):733-8.

34.

The spectrum of circulating immune complexes in various forms of systemic small vessel vasculitis.

Kauffmann RH, Valentijn RM.

Neth J Med. 1982;25(7):193-201. No abstract available.

PMID:
7144989
35.
36.

Presence of immune complex-like material in sera of patients with paraproteinaemia.

Klein F, Lafeber GJ, Jongepier-Geerdes YE, Cats A, Kauffmann RH, Michiels JJ.

J Clin Pathol. 1981 Sep;34(9):1036-9.

37.

The clinical implications and the pathogenetic significance of circulating immune complexes in infective endocarditis.

Kauffmann RH, Thompson J, Valentijn RM, Daha MR, Van Es LA.

Am J Med. 1981 Jul;71(1):17-25.

PMID:
7246577
38.

The specific detection of IgA in immune complexes.

Kauffmann RH, Van Es LA, Daha MR.

J Immunol Methods. 1981;40(2):117-29.

PMID:
7019333
39.
40.

Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.

Kauffmann RH, Herrmann WA, Meijer CJ, Daha MR, Vanes LA.

Clin Exp Immunol. 1980 Sep;41(3):459-70.

41.

Extreme potassium loss in a patient with severe graft versus host disease.

Tricot GJ, Zwaan FE, Kauffmann RH, Jansen J, Haak HL.

Scand J Haematol. 1980 Sep;25(3):264-7.

PMID:
7008182
42.

Allergic vasculitis. A histological and immunofluorescent study of lesional and non-lesional skin in relation to circulating immune complexes.

Herrmann WA, Kauffmann RH, van Es LA, Daha MR, Meijer CJ.

Arch Dermatol Res. 1980;269(2):179-87.

PMID:
7006520
43.

Treatment of cytomegalovirus pneumonitis with hyperimmune plasma.

Dijkmans BA, Versteeg J, Kauffmann RH, van den Broek PJ, Eernisse JG, van Zanten JJ, Bakker W, Kalff MW, van Hooff JP.

Lancet. 1979 Apr 14;1(8120):820-1. No abstract available.

PMID:
86057
44.

Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection.

Kauffmann RH, Van Es LA, Daha MR.

J Immunol Methods. 1979;31(1-2):11-22.

PMID:
390054
45.

Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome.

Kauffmann RH, Veltkamp JJ, Van Tilburg NH, Van Es LA.

Am J Med. 1978 Oct;65(4):607-13.

PMID:
707521
46.

Unilateral renal vein thrombosis and nephrotic syndrome. Report of a case with protein selectivity and antithrombin III clearance studies.

Kauffmann RH, de Graeff J, de la Rivière GB, van Es LA.

Am J Med. 1976 Jun;60(7):1048-54.

PMID:
937349

Supplemental Content

Loading ...
Support Center